Log in

Akebia Therapeutics Earnings Date, Estimates & History (NASDAQ:AKBA)

-0.53 (-6.00 %)
(As of 02/28/2020 07:43 AM ET)
Today's Range
Now: $8.30
50-Day Range
MA: $8.29
52-Week Range
Now: $8.30
Volume2.08 million shs
Average Volume1.33 million shs
Market Capitalization$987.20 million
P/E RatioN/A
Dividend YieldN/A


Akebia Therapeutics has confirmed that its next quarterly earnings report will be published on Tuesday, March 10th, 2020. Akebia Therapeutics will be holding an earnings conference call on Tuesday, March 10th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Akebia Therapeutics Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Akebia Therapeutics (NASDAQ:AKBA) Earnings Estimates

2020 EPS Consensus Estimate: ($1.19)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20201($0.27)($0.27)($0.27)
Q2 20201($0.49)($0.49)($0.49)
Q3 20201($0.28)($0.28)($0.28)
Q4 20201($0.15)($0.15)($0.15)
Q1 20211($0.41)($0.41)($0.41)
Q2 20211($0.40)($0.40)($0.40)
Q3 20211($0.38)($0.38)($0.38)

Akebia Therapeutics (NASDAQ AKBA) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
 ($0.44)    Register (Before Market Opens)
11/12/2019Q3 2019($0.37)($0.4592)($0.10)$93.94 million$91.98 millionTranscript
8/8/2019Q2 2019($0.35)($0.30)($0.11)$88.35 million$100.80 millionN/A
5/9/20193/31/2019($0.42)($0.44)($0.26)$83.69 million$72.67 millionN/A
3/26/2019Q4 2018($0.27)($0.91)($0.89)$78.87 million$59.85 millionN/A
11/8/2018Q3($0.6410)($0.46)($0.46)$39.71 million$53.17 millionN/A
8/8/2018Q2 2018($0.51)($0.60)($0.60)$48.75 million$48.79 millionN/A
5/9/2018Q1 2018($0.49)($0.48)($0.48)$47.80 million$45.93 millionN/A
3/12/2018Q4 2017($0.36)$0.25$0.25$66.00 million$87.32 millionTranscript
11/8/2017Q3 2017($0.56)($0.49)($0.49)$34.00 million$41.28 millionN/A
8/8/2017Q2 2017($0.89)($0.53)($0.53)$26.50 million$28.52 millionN/A
5/9/2017Q1 2017($0.15)($1.15)($1.15)$16.50 million$20.87 millionN/A
3/6/2017Q4 2016$0.77($0.99)($0.99)$125.00 million$1.54 millionListen
8/8/2016Q2 2016($0.57)($0.95)($0.95)$6.00 millionN/A
5/5/2016Q1 2016($0.43)($0.70)($0.70)$9.00 millionN/A
3/14/2016Q415($0.28)($0.66)($0.66)$11.60 millionListen
5/11/2015Q1 2015($0.57)($0.53)($0.53)N/A
8/11/2014Q2 2014($0.34)($0.39)($0.39)N/A
5/12/2014Q1 2014($43.37)($43.37)N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 2/28/2020 by MarketBeat.com Staff

Featured Article: Do You Need a Fiduciary?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel